Just optimize it with the Aurora Suite™

Tech-Driven Optimization for Clinical Trials

Where trial design, planning, and execution become one

Experience Metrics & Assets (4).png
Experience Metrics & Assets (6).png
Experience Metrics & Assets (5).png
Experience Metrics & Assets (7).png

Designed for Your Organisation

If you work in the Biotech or Pharma industry, represent a Contract Research Organisation (CRO), or academic/ research focused institute the Aurora Suite™ can help you.

Academic

Biotech

CRO

Pharma

Healthcare

Validated by Real Projects

See how our research, published by the European Society of Medical Oncology (ESMO) titled ‘Revolutionizing Clinical Trials: Harnessing Artificial Intelligence for Optimized Phase III Studies in Pancreatic Cancer’, validates key performance benefits for our users.

21%

Faster Site Activation

27%

Faster LPI

200%

Faster Enrolment

80%

Time Savings

With Key Benefits Built-in

Read our article published by Applied Clinical Trials titled ‘Industry Perspectives on the Key Challenges in Trial Optimization’ to understand our expertise on first hand experience on key pain points in the industry.

Save Time

Reduce Costs

Optimize Clinical Trials

Built for Actionable Insights

The Aurora Suite™ flips the script with a focus on producing actionable insights by considering trends across datasets, rather than treating them as isolated pieces of information.

Our Core Pillars

An tech-driven platform that integrates our core pillars (analytics, technology, and data) to enhance trial design, planning, and execution.

Analytics

Tech

Data

Join a Growing Community

Followers

Visits

Access the Aurora Suite™

Standalone Projects

Discover how our technology can enhance clinical trial setup, including RFPs, strategy development, RFIs, and budgeting. Let us help you conduct thorough feasibility assessments for your upcoming projects, with all Aurora Analytica systems and data included.

Enterprise Subscription

Users access the platform with an enterprise subscription that includes advanced two-factor authentication (2FA) for better security. We also offer plenty of storage, the option to assign different user roles for better team management, and a convenient mobile view.

Testimonials

  • "Aurora holds great potential for improving clinical trial performance. The innovative features, design and focus on relevant data make it a game-changer!"

    Past CEO, CRO (Nordics)

  • "Working in feasibility for many years, I hoped that something like this would come along. This will definitely save me a great deal of time. Can't wait to test it!"

    Past Global Feasibility Director, CRO

  • "...the extent to which the proposed work is breakthrough and goes beyond the state of the art are very good."

    European Innovation Council (EIC)

Step into the future of clinical trials

Use the Aurora Suite to turn data and expertise into high-performing clinical trial strategies, fast.

Featured News
Aurora Analytica Recognized by the EIC for Its Ground-breaking Innovation
Aurora Analytica Recognized by the EIC for Its Ground-breaking Innovation

Recently, we had the opportunity to present our vision to the European Innovation Council (EIC) as part of a detailed and comprehensive evaluation process. Their response reinforced the strength of our approach and the transformational potential of the Aurora Suite.

Read More →
Aurora Analytica Awarded Innovation Norway Start-up 2 Grant
Aurora Analytica Awarded Innovation Norway Start-up 2 Grant

We are thrilled to announce that Aurora Analytica has been awarded the prestigious Start-up 2 (Oppstart 2) grant from Innovation Norway.

Read More →
Optimizing Mental Health Trials: Delivering Actionable Insights and Efficiency
Optimizing Mental Health Trials: Delivering Actionable Insights and Efficiency

By leveraging our expertise and proprietary decision engines, we provided a comprehensive assessment of trial feasibility, competitive landscape, and site intelligence, helping our client reduce uncertainty and optimize trial planning. The results?

Read More →
Aurora Analytica Article Published by Applied Clinical Trials Magazine
Aurora Analytica Article Published by Applied Clinical Trials Magazine

In this article, Bhavish Lekh (CEO) drawsfrom over 10 years of experience in feasibility and predictive analytics at top companies such as IQVIA, Medpace, Synteract, and Syneos Health. Bhavish explores key obstacles for Pharma, Biotech, and CROs, including the high costs of clinical trials, particularly the hidden costs associated with trial setup.

Read More →
Behind Aurora Analytica: Our Motivation, Mission & The Aurora Suite™
Behind Aurora Analytica: Our Motivation, Mission & The Aurora Suite™

At Aurora Analytica, we are driven by a clear mission: to transform clinical research through the power of analytics, data, and AI—accelerating trials, improving quality, and ultimately getting treatments to patients faster.

Read More →
Introducing Starlite-AI: Our Latest Step Toward Intelligent Clinical Trial Optimization
Introducing Starlite-AI: Our Latest Step Toward Intelligent Clinical Trial Optimization

Our advanced AI model built to transform clinical trials with automation, streamlined design, data-driven recommendations, and insights across millions of data points.

Read More →
Announcing the Aurora Suite™ Teaser Video: A Glimpse into the Future of Clinical Trials
Announcing the Aurora Suite™ Teaser Video: A Glimpse into the Future of Clinical Trials

We are thrilled to announce the release of our Aurora Suite™ Teaser Video! This exciting video provides a sneak peek into the revolutionary capabilities of our suite of tools designed to transform the clinical trial landscape.

Read More →
Aurora Analytica Article Published by Applied Clinical Trials Magazine
Aurora Analytica Article Published by Applied Clinical Trials Magazine

Our article delves into the most pressing issues facing the pharmaceutical industry today, specifically around optimizing clinical trials. Backed by real-world perspectives gathered from our Aurora Analytica Insights Survey, we discuss views of industry stakeholders across Biotech, Pharma, and CROs.

Read More →
Optimizing Phase III Trials in Pancreatic Cancer - ESMO Poster 2024
Optimizing Phase III Trials in Pancreatic Cancer - ESMO Poster 2024

Using the Aurora Suite we compared the phase III trial 'POLO' with our results. The Aurora Suite could have enabled POLO to enroll more than 200% higher, whilst reducing sites required and enrollment time by ~30%.

Read More →
Aurora Analytica Presents at ESMO, Barcelona, 2024
News
Aurora Analytica Presents at ESMO, Barcelona, 2024
News

We present our poster, "Revolutionizing Clinical Trials: Harnessing Artificial Intelligence for Optimized Phase III Studies in Pancreatic Cancer.

Read More →
News
Aurora Analytica Receives Innovation Norway Grant to Drive Clinical Trial Optimization Innovation
Aurora Analytica Receives Innovation Norway Grant to Drive Clinical Trial Optimization Innovation

We are thrilled to announce that Aurora Analytica has been awarded a prestigious grant from Innovation Norway.

Read More →
Introducing Aurora Consulting
Introducing Aurora Consulting

At the heart of Aurora Consulting's mission is a profound dedication to your project's triumph. Our foundation is built on understanding and addressing the pivotal questions that shape the landscape of healthcare innovation.

Read More →
Aurora Analytica’s Pioneering Ready-to-Use Solutions for Immediate Impact
Blog
Aurora Analytica’s Pioneering Ready-to-Use Solutions for Immediate Impact
Blog

In an era where promises often outweigh performance, the frustration of waiting for a product to deliver on its claims is all too common. At Aurora Analytica, we understand this sentiment and have made it our mission to redefine the customer experience by offering solutions that are not only ready to use from day one but also continuously evolving to exceed your expectations.

Read More →
Blog
Decoding the Global Puzzle
Blog
Decoding the Global Puzzle
Blog

Decoding the Global Puzzle: Aurora Analytica's Geo Matrix™ Unravels Clinical Trial Country Selection Challenges

Read More →
Blog
Aurora Analytica AS Secures Seed Funding to Fuel Product Development.
News
Aurora Analytica AS Secures Seed Funding to Fuel Product Development.
News

Oslo, Norway, 16th January 2024 – Aurora Analytica has successfully raised an undisclosed amount in seed funding. The funding will be used to accelerate the company's ongoing product development efforts and strengthen its position in the healthcare research sector.

Read More →
News
Aurora Analytica AS Welcomes Bhavish Lekh as Chief Executive Officer.
News
Aurora Analytica AS Welcomes Bhavish Lekh as Chief Executive Officer.
News

Oslo, Norway, 14th December 2023 – Aurora Analytica AS, a pioneering healthcare analytics and data company, is delighted to announce the appointment of Bhavish Lekh as CEO.

Read More →
News
Aurora Analytica AS Welcomes Dr Ola Gudmundsen as Chairman of the Board.
News
Aurora Analytica AS Welcomes Dr Ola Gudmundsen as Chairman of the Board.
News

Oslo, Norway, 11th December 2023 – Aurora Analytica AS, a pioneering healthcare analytics and data company, is delighted to announce the appointment of Ola Gudmundsen to its board of directors, as Chairman of the Board.

Read More →
News
Illuminating the Path: Introducing Aurora Analytica
News
Illuminating the Path: Introducing Aurora Analytica
News

We are thrilled to announce the birth of a new era in healthcare analytics: Aurora Analytica. At Aurora Analytica, we believe in the transformative power of data, and our mission is to empower healthcare pioneers to re-envision the possibilities within their reach.

Read More →
News